Cargando…
Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer
Background: Triple-negative breast cancer (TNBC) is one of the most prevalent neoplastic diseases worldwide, but efficacious treatments for this pathological condition are still challenging. The lack of an effective targeted therapy also leads to a poor prognosis for patients affected by TNBC. In th...
Autores principales: | Zhen, Yongqi, Zhao, Rongyan, Wang, Minjuan, Jiang, Xing, Gao, Feng, Fu, Leilei, Zhang, Lan, Zhou, Xian-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381743/ https://www.ncbi.nlm.nih.gov/pubmed/32724459 http://dx.doi.org/10.7150/thno.43473 |
Ejemplares similares
-
Flubendazole induces mitochondrial dysfunction and DRP1-mediated mitophagy by targeting EVA1A in breast cancer
por: Zhen, Yongqi, et al.
Publicado: (2022) -
Flubendazole Elicits Antitumor Effects by Inhibiting STAT3 and Activating Autophagy in Non-small Cell Lung Cancer
por: Xie, Xiaona, et al.
Publicado: (2021) -
Flubendazole Enhances the Inhibitory Effect of Paclitaxel via HIF1α/PI3K/AKT Signaling Pathways in Breast Cancer
por: Zhou, Yuxin, et al.
Publicado: (2023) -
Flubendazole Plays an Important Anti-Tumor Role in Different Types of Cancers
por: Chen, Chaoran, et al.
Publicado: (2022) -
Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy
por: Lin, Shichong, et al.
Publicado: (2019)